Trials / Unknown
UnknownNCT05494775
Effect of Corona Virus on Intravitreal Injections
Effects of Corona Virus Pandemic on Intravitreal Injections
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 250 (estimated)
- Sponsor
- Benha University · Academic / Other
- Sex
- All
- Age
- 30 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
During pandemic of corona virus, patients compliance may be affected. We aim to study the factors lead to unregulated visits and its implications on the final visual outcome.
Detailed description
The corona virus pandemic may affects patients regular visits to ophthalmic clinic, we aim to study the sequel of the pandemic on intravitreal injections results in diabetic macular edema, wet age related macular degenerations, myopic choroidal new vascularization, and proliferative diabetic retinopathy.
Conditions
- Diabetic Macular Edema
- Age-Related Macular Degeneration
- Choroidal Neovascularization
- Myopic Choroidal Neovascularisation
- Diabetic Retinopathy
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Anti-vascular endothelial growth factors (Anti-VEGFs) | Intravitreal injection of anti-vascular endothelial growth factors (Anti-VEGFs). |
Timeline
- Start date
- 2019-02-01
- Primary completion
- 2023-06-11
- Completion
- 2023-07-30
- First posted
- 2022-08-10
- Last updated
- 2022-08-10
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05494775. Inclusion in this directory is not an endorsement.